# Ube to acquire API Corporation from Mitsubishi Chemical

Ube has agreed to acquire all shares of API Corporation, a CDMO and API manufacturer, from Mitsubishi Chemical. APIC provides services from synthetic route design to commercial production for small molecule drugs.

- Type: Acquisition
- Announced: 2022-09-08
- Where: Japan
- Status: announced
- Products: active pharmaceutical ingredients, CDMO services
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [API Group](https://endata.com/companies/3052.md) (target)
- [Mitsubishi Chemical Corporation](https://endata.com/companies/5545.md) (partner)
- [UBE Corporation](https://endata.com/companies/43908.md) (acquirer)

## Sources

- [viewer.joomag.com](https://viewer.joomag.com/speciality-chemicals-magazine-sept-oct-2022/0608782001662132063/p7), 2022-09-08: "Japan's Ube has agreed to acquire all of the shares of the CDMO and API manufacturer API Corporation from its compatriot Mitsubishi Chemical."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
